Although slim on details, Heidi Shyu told reporters today that DoD will conduct a Technology Readiness Experimentation event sometime this year with its Australian counterparts and will conduct a new sprint of RDER with them next year.
By Jaspreet GillDoD’s new Biomanufacturing Strategy and an accompanying RFI from industry both aim to help companies using biological processes to make potentially revolutionary materials — and to keep them from moving offshore like semiconductors.
By Sydney J. Freedberg Jr.A month after a think tank said US was losing race to China, DoD hopes the tech will help fix a number of problems, including avoiding supply chain woes.
By Lee Ferran“A successful U.S. biotechnology strategy will not be about biotechnology on its own; it will connect growth in the biotech industry to broader U.S. strategic objectives […],” according to a new CNAS report.
By Jaspreet Gill“These efforts are not about creating physical traits that don’t already exist naturally. This is about enhancing the mission readiness of our forces by improving performance characteristics that typically decline with age,” Cmdr. Tim Hawkins, SOCOM spokesperson, said.
By Theresa Hitchens“Our ability to apply AI and other emerging technologies faster than our adversaries will allow us to maintain our competitive edge over Russia and China,” Rep. Elise Stefanik, ranking of the HASC emerging threats subcommittee, said.
By Theresa HitchensThe Army launched its Shark Tank-style xTechSearch before coronavirus hit, but several of the small firms competing for $1.2 million in prizes are working on ways to help.
By Sydney J. Freedberg Jr.This “key new initiative,” Griffin stressed, could lead to DoD being able to such breakthroughs as creating its own fuel.
By Theresa HitchensInstead of augmenting super-soldiers, DARPA wants to boost troops’ natural defenses against engineered diseases — and even undo gene-editing altogether.
By Sydney J. Freedberg Jr.From repelling bugs to protecting divers in dangerous waters, scientists are pushing the boundaries of biotech.
By Sydney J. Freedberg Jr.UPDATED: Adds Text Of SecDef Mattis’ Speech At SAIS WASHINGTON: The Trump Administration’s first National Defense Strategy is a vigorously and well written document that marks a major shift from the policies of the Obama and Bush Administrations, calling China and Russia the “central challenge” to the United States. The strategy, a late draft of…
By Colin ClarkUPDATED: Carter Touts Import Of Biotech CAMBRIDGE, MASS.: Special operations troops will test a high-tech headset that “uses noninvasive electrical stimulation” to help the brain learn better marksmanship and hand-to-hand combat skills, Defense Secretary Ashton Carter said here today. This cutting edge example of “enhanced human operations” — a highly controversial field — is just…
By Sydney J. Freedberg Jr.
Bill Greenwalt is sort of the Pied Piper of military acquisition policy. Where he leads, others often follow. After he wrote a series of op-eds for Breaking Defense recommending major changes to the Pentagon’s acquisition system, Sen. John McCain lured Bill back to his old job at the Senate Armed Services Committee. Greenwalt rewrote the laws, shaking up Defense Department acquisition. Bill is back, pointing to new acquisition problems, this latest one with his former employer — the Government Accountability Office. It’s a doozy, as you’ll see.
By Bill Greenwalt